Skip Nav Destination
How I treat first relapse of myeloma
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding
Issue Archive
August 24 2017
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
HOW I TREAT
How I treat first relapse of myeloma
Clinical Trials & Observations
CLINICAL TRIALS AND OBSERVATIONS
Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Clinical Trials & Observations
Ajai Chari,Attaya Suvannasankha,Joseph W. Fay,Bertrand Arnulf,Jonathan L. Kaufman,Jainulabdeen J. Ifthikharuddin,Brendan M. Weiss,Amrita Krishnan,Suzanne Lentzsch,Raymond Comenzo,Jianping Wang,Kerri Nottage,Christopher Chiu,Nushmia Z. Khokhar,Tahamtan Ahmadi,Sagar Lonial
IMMUNOBIOLOGY AND IMMUNOTHERAPY
LYMPHOID NEOPLASIA
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek,Jingda Xu,Stefan Köhrer,Zhiqiang Wang,Lisa Becker,Justin M. Comer,Jared Henderson,Wencai Ma,John Man Chun Ma,Jason R. Westin,Dipanjan Ghosh,Nicholas Shinners,Luhong Sun,Allen F. Yi,Anusha R. Karri,Jan A. Burger,Tomasz Zal,R. Eric Davis
MYELOID NEOPLASIA
High prevalence of myeloid neoplasms in adults with non–Langerhans cell histiocytosis
Matthias Papo,Eli L. Diamond,Fleur Cohen-Aubart,Jean-François Emile,Damien Roos-Weil,Nishant Gupta,Benjamin H. Durham,Neval Ozkaya,Ahmet Dogan,Gary A. Ulaner,Raajit Rampal,Jean-Emmanuel Kahn,Thomas Sené,Frédéric Charlotte,Baptiste Hervier,Caroline Besnard,Olivier A. Bernard,Catherine Settegrana,Nathalie Droin,Zofia Hélias-Rodzewicz,Zahir Amoura,Omar Abdel-Wahab,Julien Haroche
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
NR4A orphan nuclear receptor family members, NR4A2 and NR4A3, regulate neutrophil number and survival
Lynne R. Prince,Svenja D. Prosseda,Kathryn Higgins,Jennifer Carlring,Elizabeth C. Prestwich,Nikolay V. Ogryzko,Atiqur Rahman,Alexander Basran,Francesco Falciani,Philip Taylor,Stephen A. Renshaw,Moira K. B. Whyte,Ian Sabroe
PLATELETS AND THROMBOPOIESIS
Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding
Clinical Trials & Observations
Brief Report
Sarah K. Westbury,Matthias Canault,Daniel Greene,Emilse Bermejo,Katharine Hanlon,Michele P. Lambert,Carolyn M. Millar,Paquita Nurden,Samya G. Obaji,Shoshana Revel-Vilk,Chris Van Geet,Kate Downes,Sofia Papadia,Salih Tuna,Christopher Watt,NIHR BioResource–Rare Diseases Consortium,Kathleen Freson,Michael A. Laffan,Willem H. Ouwehand,Marie-Christine Alessi,Ernest Turro,Andrew D. Mumford
RED CELLS, IRON, AND ERYTHROPOIESIS
Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress
Antonella Pantaleo,Kristina R. Kesely,Maria Carmina Pau,Ioannis Tsamesidis,Evelin Schwarzer,Oleksii A. Skorokhod,Huynh D. Chien,Marta Ponzi,Lucia Bertuccini,Philip S. Low,Francesco M. Turrini
TRANSFUSION MEDICINE
TRANSPLANTATION
BLOOD WORK
ERRATUM
-
Cover Image
Cover Image
In the cell line HBL-1, representing the activated B-cell subtype of diffuse large B-cell lymphoma, superresolution microscopy with a red fluorescent dye shows the convoluted plasma membrane of a living cell in culture. See the article by Havranek et al on page 995.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals